Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Spradling

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Racial and Ethnic Health Disparities|March 13, 2024
Disparities in Social Vulnerability and Premature Mortality among Decedents with Hepatitis B, United States, 2010-2019Kathleen N Ly, Shaoman Yin, Philip R Spradling
JAMA Network Open|June 28, 2022
Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019Kathleen N Ly, Shaoman Yin, Philip R Spradling
The Journal of Infectious Diseases|April 27, 2021
Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018Kathleen N Ly, Jian Xing, Philip R Spradling
Diabetes Care|November 23, 2012
Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literatureSarah F Schillie, Philip R Spradling, Trudy V Murphy
Infection Control and Hospital Epidemiology|July 20, 2011
Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United StatesRania A Tohme, Bruce Ribner, Michael J Huey, et al.
The Journal of Infectious Diseases|July 12, 2021
Estimated Prevalence and Number of Persons With Isolated Antibody to Hepatitis B Core Antigen and Associated Occult Hepatitis B, United States, 2001-2018Philip R Spradling, Jian Xing, Aaron M Harris, et al.
Journal of Viral Hepatitis|September 3, 2024
Evolving Characteristics of Decedents With Hepatitis A Listed as a Cause of Death, United States, 2011-2021Megan G Hofmeister, Kathleen N Ly, Shaoman Yin, et al.
Infection Control and Hospital Epidemiology|June 7, 2012
Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United StatesPhilip R Spradling, Roxanne E Williams, Jian Xing, et al.
The New England Journal of Medicine|May 17, 2013
Hepatitis C in the United StatesScott D Holmberg, Philip R Spradling, Anne C Moorman, et al.
Applied Health Economics and Health Policy|August 3, 2016
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver DiseaseAndrew J Leidner, Harrell W Chesson, Philip R Spradling, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Racial and Ethnic Health Disparities|March 13, 2024
Disparities in Social Vulnerability and Premature Mortality among Decedents with Hepatitis B, United States, 2010-2019Kathleen N Ly, Shaoman Yin, Philip R Spradling
JAMA Network Open|June 28, 2022
Regional Differences in Mortality Rates and Characteristics of Decedents With Hepatitis B Listed as a Cause of Death, United States, 2000-2019Kathleen N Ly, Shaoman Yin, Philip R Spradling
The Journal of Infectious Diseases|April 27, 2021
Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001-2018Kathleen N Ly, Jian Xing, Philip R Spradling
Diabetes Care|November 23, 2012
Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literatureSarah F Schillie, Philip R Spradling, Trudy V Murphy
Infection Control and Hospital Epidemiology|July 20, 2011
Hepatitis B vaccination coverage and documented seroprotection among matriculating healthcare students at an academic institution in the United StatesRania A Tohme, Bruce Ribner, Michael J Huey, et al.
The Journal of Infectious Diseases|July 12, 2021
Estimated Prevalence and Number of Persons With Isolated Antibody to Hepatitis B Core Antigen and Associated Occult Hepatitis B, United States, 2001-2018Philip R Spradling, Jian Xing, Aaron M Harris, et al.
Journal of Viral Hepatitis|September 3, 2024
Evolving Characteristics of Decedents With Hepatitis A Listed as a Cause of Death, United States, 2011-2021Megan G Hofmeister, Kathleen N Ly, Shaoman Yin, et al.
Infection Control and Hospital Epidemiology|June 7, 2012
Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United StatesPhilip R Spradling, Roxanne E Williams, Jian Xing, et al.
The New England Journal of Medicine|May 17, 2013
Hepatitis C in the United StatesScott D Holmberg, Philip R Spradling, Anne C Moorman, et al.
Applied Health Economics and Health Policy|August 3, 2016
Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver DiseaseAndrew J Leidner, Harrell W Chesson, Philip R Spradling, et al.
Pageof 9